Journal
CEPHALALGIA
Volume 38, Issue 5, Pages 815-832Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102418758283
Keywords
Chronic migraine; clinical trials; headache; drugs; preventive treatment
Categories
Ask authors/readers for more resources
Background Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available